Barroilhet evaluates endometrial cancer data in Targeted Oncology

Lisa Barroilhet, MD, MS, director of the Division of Gynecologic Oncology, discussed trials that may be of interest for patients with recurrent endometrial cancer with Targeted Oncology during a Case-Based Roundtable event. In the discussion, Barroilhet reviewed data from a few recent trials for patients with recurrent endometrial cancer. She shared patient characteristics i... more

Barroilhet discusses gynecologic cancer signs and symptoms with WISN

During Gynecologic Cancer Awareness Month in September, Lisa Barroilhet, MD, MS, associate professor in the Division of Gynecologic Oncology, joined WISN 12 News to share common gynecologic cancer signs and symptoms.In the interview, Barroilhet outlined the variety of gynecologic cancers, risk factors for developing different types of gynecologic cancers, warning signs or sy... more

Barroilhet discusses PARP inhibitors with OncLive

Lisa Barroilhet, MD, MS, associate professor in the Division of Gynecologic Oncology, joined OncLive to talk about the role of PARP inhibitors for patients with ovarian cancer. In the video, Barroilhet discusses findings from two trials that seem encouraging for PARP inhibitor use: “All patients with ovarian cancer displaying somatic or germline BRCA mutations should receiv... more

Barroilhet publishes editorial in Gynecologic Oncology Reports

Lisa Barroilhet, MD, MS, associate professor in the Division of Gynecologic Oncology, published an editorial about the intersection of gynecologic cancer care and post-Dobbs restrictions on health care in Gynecologic Oncology Reports. In “Editorial on vaginal cancer diagnosed in pregnancy and current abortion law on cancer care in Louisiana”, Barroilhet lays out the ways abo... more

Barroilhet co-authors article in Abdominal Radiology

Lisa Barroilhet, MD, MS, associate professor in the Division of Gynecologic Oncology, co-authored a new study published in Abdominal Radiology. In “Distribution of prostate specific membrane antigen (PSMA) on PET-MRI in patients with and without ovarian cancer”, Barroilhet and co-authors outline a proof-of-concept study comparing the results of an imaging protocol in patient... more

Leadership transition in the Division of Gynecologic Oncology

Later this fall, the UW Ob-Gyn Division of Gynecologic Oncology will undergo a leadership transition: Stephen Rose, MD, who has served as Division Director of Gynecologic Oncology since 2017, will step down from that role. Dr. Lisa Barroilhet, MD, MS will become the new Division Director on November 13, 2023. Please help us thank Dr. Rose for his steadfast, supportive, and i... more

Barroilhet, Wallace co-author review article in Radiology

Associate Professor Lisa Barroilhet, MD, MS, and Associate Professor Sumer Wallace, MD, MS, co-authored a review article in the journal Radiology. In “Adnexal Lesion Imaging: Past, Present, and Future”, Barroilhet, Wallace, and co-authors discuss ways imaging has affected treatment of adnexal lesions, current data supporting the use of ultrasound, MRI, and CT imaging to diff... more

Barroilhet appointed co-DOT leader of Chemoprevention

Congratulations to Lisa Barroilhet, MD, MS, associate professor in the Division of Gynecologic Oncology! Barroilhet was appointed co-leader of the UW Carbone Cancer Center’s Chemoprevention Disease-Oriented Team. She will lead the team alongside Howard Bailey, MD, associate dean for oncology at the University of Wisconsin School of Medicine and Public Health and director of ... more

Barroilhet selected as 2023-2024 Hedwig van Ameringen Executive Leadership in Academic Medicine Program fellow

Huge congratulations to Lisa Barroilhet, MD, MS, associate professor in the Division of Gynecologic Oncology! Barroilhet was selected as a 2023-24 Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program fellow!The ELAM Program, offered by the Drexel University College of Medicine, is a year-long, part-time fellowship for women faculty in schools of med... more

Patankar Lab publishes study on endometriosis treatment in Reproduction

According to the World Health Organization, endometriosis affects roughly 10 percent of reproductive-aged women around the world; despite this prevalence, treatment options are limited. In a new study in Reproduction, members of the Patankar Lab describe a novel treatment strategy for the disease.“Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis ce... more

Barroilhet, Giles, Iruretagoyena in Texas as Board Examiners

Three UW Ob-Gyn faculty served as ABOG subspecialty board examiners in Texas this year!Dobie Giles, MD, MS, MBA, professor in the Division of Female Pelvic Medicine and Reconstructive Surgery, Lisa Barroilhet, MD, MS, associate professor in the Division of Gynecologic Oncology, and Igor Iruretagoyena, MD, MS, professor and director of the Division of Maternal-Fetal Medicine,... more

UW Ob-Gyn presentations at 2023 Society of Gynecologic Oncology conference

UW Ob-Gyn faculty, advanced practice providers, fellows, and residents prepared an impressive slate of presentations and posters, and served in key leadership roles, for the 2023 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer! Here are just some of their exciting contributions to the conference, which took place March 25-28, 2023 in Tampa, FL:Associate Proe... more

Residency alum Carballo publishes in Scientific Reports

Erica Carballo, MD, UW Ob-Gyn residency graduate in the class of 2021, published a new article in Scientific Reports! Lisa Barroilhet, MD, MS, associate professor in the Division of Gynecologic Oncology, is senior author on the article.In “Surgical outcomes of adnexal masses classified by IOTA ultrasound simple rules”, Carballo and co-authors conducted a retrospective study ... more

Barroilhet earns GWIMS Impact Award

Congratulations to Lisa Barroilhet, MD, MS, associate professor in the UW Ob-Gyn Division of Gynecologic Oncology! Barroilhet earned the 2022 UW School of Medicine and Public Health Group on Women in Medicine and Science Impact Award! The award was presented at a ceremony on November 29, 2022.The Impact Award recognizes significant contributions with ongoing, substantive imp... more

Barroilhet presents keynote speech at Middleton Society event

On September 30, 2022, Lisa Barroilhet, MD, MS, associate professor in the UW Ob-Gyn Division of Gynecologic Oncology, presented the keynote speech at the UW School of Medicine and Public Health’s Middleton Society event.Barroilhet presented “Women Need Us Now: The Science and Strategy of Cancer Prevention” to an audience of UW SMPH alumni, friends, and supporters. In her ta... more

Barroilhet joins Crossing the Line podcast to discuss Dobbs’ impact on health care

On a recent episode of the new podcast Crossing the Line, Lisa Barroilhet, MD, MS, associate professor in the Division of Gynecologic Oncology, discussed Wisconsin’s abortion ban and the challenges of navigating the “life of the mother” exception.In the episode “A Matter of Life or Death”, Barroilhet talks about the lack of clarity that affects the kinds of health care patie... more

Grand Rounds: Barroilhet presents “The Dobbs Decision: Implications for Health Care in Wisconsin”

On October 6, 2022, UW Ob-Gyn Associate Professor Lisa Barroilhet, MD, MS, presented the Grand Rounds lecture “The Dobbs Decision: Implications for Health Care in Wisconsin”.In the lecture, Barroilhet explained current law surrounding abortion care in Wisconsin, outlined some clinical situations where abortion would be legal under today’s law, and discussed access to abortio... more

Barroilhet joins WPR to talk about impacts of Wisconsin abortion laws

During her time as interim chair of the UW Department of Ob-Gyn, Associate Professor Lisa Barroilhet, MD, MS spoke with Wisconsin Public Radio on two occasions about the impacts of Wisconsin’s 1849 law restricting the availability of abortion care in the state.In Wisconsin, what are my options if genetic testing shows the fetus isn't viable? – WHYsconsinIn this listener-ques... more

Barroilhet discusses challenges of post-Dobbs health care with Wisconsin Watch

In a new article, media outlet Wisconsin Watch highlights the effects of Wisconsin’s 173-year-old abortion ban law on patient care. In the article, Lisa Barroilhet, MD, MS, associate professor in the UW Ob-Gyn Division of Gynecologic Oncology, weighed in about the challenges of interpreting the law’s exception for “therapeutic abortions”:““It’s really important to understand... more

Barroilhet and Patankar publish in Cancers

A new study co-authored by Lisa Barroilhet, MD, of the UW Ob-Gyn Division of Gynecologic Oncology and Division of Reproductive Sciences Director Manish Patankar, PhD was published in the journal Cancers!“Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers” outlines the Barroilhet and Patankar Labs’ research of the FDA-approved antimalarial... more

Barroilhet/Patankar Labs celebrate graduates

The research labs of interim department chair Lisa Barriolhet, MD, MS and Division of Reproductive Sciences Director Manish Patankar, PhD celebrated some amazing graduates in May!Please help us congratulate Lojain Ibrahim Aljohani, MS and Kristal Gant, PhD, who graduated from the UW-Madison Endocrinology & Reproductive Physiology program, and Shannon Rush, MD, graduating UW ... more

Sobecki published in International Journal of Gynecologic Cancer

Janelle Sobecki, MD, of the UW Ob-Gyn Division of Gynecologic Oncology, is lead author on a new study published in the International Journal of Gynecologic Cancer!In “Opportunistic osteoporosis screening using routine computed tomography images to identify bone loss in gynecologic cancer survivors”, Sobecki and co-authors (including gynecologic oncology faculty Lisa Barroilh... more

UW Ob-Gyn presentations at 2022 Society of Gynecologic Oncology conference

Members of the UW Ob-Gyn Division of Gynecologic Oncology, fellows and residents prepared an impressive slate of posters and presentations for the 2022 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer! Take a look at just some of the research brought to the hybrid conference, as well as the variety of service and leadership roles held by members of our depart... more

Wagar published in Journal of Ob-Gyn Hospital Medicine

A new article in the latest issue of the Journal of Ob-Gyn Hospital Medicine looks at rates of removal of fallopian tubes during postpartum sterilization procedures.“Trends in Postpartum Opportunistic Salpingectomy During Vaginal Delivery Admissions”, by UW Ob-Gyn resident Matt Wagar, MD, PGY-4 and co-authors Amy Godecker, PhD, Maria Landeros, Lisa Barroilhet, MD MS, and Mak... more

Wagar published in Gynecologic Oncology

A new article in the journal Gynecologic Oncology by UW Ob-Gyn resident Matt Wagar, MD, PGY-4 examines whether enrollments in clinical trials for PARP inhibitors reflects the racial and ethnic diversity of people who are diagnosed with ovarian cancer.“Racial and ethnic enrollment disparities in clinical trials of poly(ADP-ribose) polymerase inhibitors for gynecologic cancers... more

Barroilhet joins ICTR Graduate Program in Clinical Investigation admissions committee

Lisa Barroilhet, MD, of the UW Ob-Gyn Division of Gynecologic Oncology, was recently invited to join the UW-Madison Institute for Clinical and Translational Research’s admissions and recruiting subcommittee for the Graduate Program in Clinical Investigation! Her three-year term began on January 1, 2022.The admissions and recruiting subcommittee makes final, program-level dec... more

Barroilhet discusses patient education with Health Professional Radio

On a recent episode of Health Professional Radio, Lisa Barroilhet, MD of the UW Ob-Gyn Division of Gynecologic Oncology, discussed the launch of the Foundation for Women’s Cancer #MoveTheMessage campaign.In the interview, Barroilhet talked about the need for greater awareness of gynecologic cancers, the importance of having accessible, inclusive education materials readily a... more

Barroilhet promoted to Associate Professor (tenure track)

Our congratulations to Lisa Barroilhet, MD, of the UW Ob-Gyn Division of Gynecologic Oncology! Barroilhet has been promoted to Associate Professor (Tenure Track). The promotion and track transfer will be effective July 1, 2021. Previously, Barroilhet was an associate professor (CHS track). Since joining the department in 2012, Barroilhet has earned a distinguished reputatio... more

Grand Rounds: Badger Bytes on opioids and women’s health

On Thursday, January 7, a multidisciplinary group presented Badger Bytes Grand Rounds lectures as part of the presentation “The Multiple Dimensions of Opioid Use for Women’s Health.” The session was moderated by UW Ob-Gyn Division of Reproductive and Population Health Director Deborah Ehrenthal, MD, MPH. Erin Nacev, MD/MPH student in the UW SMPH started off with “Prenatal O... more

First HAGO Conference was a great success!

On September 10-11, the UW Ob-Gyn Division of Gynecologic Oncology hosted the first-ever Heartland Association of Gynecologic Oncology (HAGO) meeting. More than 70 gynecologic oncology professionals tuned in for the virtual conference, which included two keynote presentations and 21 research abstract presentations.HAGO was founded in 2020 by UW Ob-Gyn Division of Gyn Onc Dir... more

Barroilhet named first-ever Dolores A. Buchler, MD, Professor in Gynecologic Oncology

A special congratulations to Lisa Barroilhet, MD, of the UW Ob-Gyn Division of Gynecologic Oncology, as she is officially appointed the first Dolores A. Buchler, MD Professor of Gynecologic Oncology. It is only once or twice a lifetime that you come across a doctor like Dolores “Dee” Buchler. Dee joined the University of Wisconsin in 1969 after finishing her residency at Uni... more